Tenon Medical (TNON) Cash from Investing Activities (2021 - 2026)
Tenon Medical's (TNON) quarterly Cash from Investing Activities came in at -$56000.0 in Q1 2026, up 70.83% quarter-over-quarter from -$192000.0 in Q4 2025.
Tenon Medical (TNON) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Tenon Medical's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$56000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$56000.0 in Q1 2026; TTM through Mar 2026 was -$850000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.0 million, down 450.0% from the prior year.
- Cash from Investing Activities grew to -$56000.0 in Q1 2026 per TNON's latest filing, from -$192000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.7 million in Q1 2023 and bottomed at -$8.2 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is -$74000.0 (2023), against an average of $156071.4.
- Across the five-year window, Cash from Investing Activities surged 140.22% in 2024 and plunged 618.92% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $2.3 million in 2022, then plunged by 103.93% to -$92000.0 in 2023, then jumped by 140.22% to $37000.0 in 2024, then plunged by 618.92% to -$192000.0 in 2025, then surged by 70.83% to -$56000.0 in 2026.
- Per Business Quant, the three latest TNON Cash from Investing Activities figures stand at -$56000.0 (Q1 2026), -$192000.0 (Q4 2025), and -$639000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Tenon Medical | 2,058.66 | -4.60 Mn | 945,000.00 | -56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56,000.00 |
| Mar 31, 2026 | -56,000.00 |
| Dec 31, 2025 | -192,000.00 |
| Dec 31, 2025 | -192,000.00 |
| Sep 30, 2025 | -639,000.00 |
| Sep 30, 2025 | -639,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | -104,000.00 |
| Sep 30, 2024 | -104,000.00 |
| Mar 31, 2024 | -119,000.00 |
| Mar 31, 2024 | -119,000.00 |
| Dec 31, 2023 | -92,000.00 |
| Dec 31, 2023 | -92,000.00 |
| Sep 30, 2023 | 436,000.00 |
| Sep 30, 2023 | 436,000.00 |
| Jun 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 4.67 Mn |
| Mar 31, 2023 | 4.67 Mn |